Zhifei Longcom Passes EU QP Audit, An Acceleration in Zhifei’s International Strategic Layout
2022-11-09
On November 8, 2022, the Recombinant COVID-19 Vaccine (CHO Cell) and the Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell) of An...
see details 》